DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Stirrups R.
Sacituzumab govitecan-hziy for triple-negative breast cancer.
Lancet Oncol 2019; pii:S1470-2045(19)30074-9
doi:10.1016/S1470-2045(19)30074-9
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.